Tumor cells can develop treatment resistance via upregulation of pro-angiogenic signals (e.g., placental growth factor or fibroblast growth factor) or by increased expression of protective pericytes that express the platelet-derived growth factor receptor. Here, PGF is linked to neoplasm.